Swedish Orphan Biovitrum AB (0MTD)
LSE
Real-time Data
07:00 AM
Day's Range
457.6052 wk Range
263.20Overview - 0MTD - Swedish Orphan Biovitrum AB
Key Statistics
Valuation
Enterprise Value
89.64B
P/E (Trailing)
‪47.33‬
PEG Ratio
‪1.94‬
Price / Sales (TTM)
‪8.29‬
Price / Book
‪4.82‬
EV / EBITDA
‪12.71‬
Profitability
Gross Margin
‪76.67%‬
Profit Margin
‪15.54%‬
Operating Margin
‪23.84%‬
Return on Assets
‪4.82%‬
Return on Equity
‪11.85%‬
Ownership
Shares Outstanding
347.28M
Float
173.41M
Held by Insiders
‪3.98%‬
Held by Institutions
‪68.47%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪458.17‬
200-Day Avg
‪400.40‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0MTD - Swedish Orphan Biovitrum AB
Peers - 0MTD - Swedish Orphan Biovitrum AB
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0MTDLSESwedish Orphan Biovitrum AB167.10BMarket Cap+37.04%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- HLNLSEHaleon plc3.19TMarket Cap+1.46%52-week change20.17P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc342.98BMarket Cap+2.31%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited159.90BMarket Cap-23.64%52-week change184.00P/E (Trailing)‪3.25%‬Profit Margin
- 0O14LSEMerck KGaA63.83BMarket Cap+20.29%52-week change19.49P/E (Trailing)‪13.95%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR50.47BMarket Cap+49.95%52-week change29.67P/E (Trailing)‪51.78%‬Profit Margin
Profile Summary - 0MTD - Swedish Orphan Biovitrum AB
About
Swedish Orphan Biovitrum AB is an international biopharmaceutical company headquartered in Stockholm, Sweden, specializing in treatments for rare diseases within haematology, immunology, and specialty care. It focuses on researching, developing, manufacturing, and commercializing innovative therapies for conditions…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
